An introduction to CBD — and what Washington might do about it - STAT

An introduction to CBD — and what Washington might do about it - STAT

More reads

• Watch: An introduction to CBD — and what Washington might do about it. (STAT)
• Celgene hands cancer drug back to BeiGene, plus $150 million. (Bloomberg)
• Chicago biotech sues Third Rock, bluebird bio CEO over gene therapy license. (Boston Business Journal)